Metraipolis › archive › dc_109fe18092ef
Enhancing anti-tumour immunity through modulating dendritic cell activation by combination therapy with a novel TLR2 agonist and PD-L1 Blockade — Europe PMC PMID:41291775
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41291775
- DOI
- 10.1186/s13046-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T07:00:56.954Z
- SHA-256 of the archived text
0f0a3a68d0bdeead4ce8ba5a01c08d8f2f8294fb047ca45256605236d9e1fdf8- Stable URL of this page
https://metraipolis.com/documento/dc_109fe18092ef
How to cite
Enhancing anti-tumour immunity through modulating dendritic cell activation by combination therapy with a novel TLR2 agonist and PD-L1 Blockade — Europe PMC PMID:41291775 — Europe PMC (en), https://europepmc.org/article/MED/41291775 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_109fe18092ef (Metraipolis archive dc_109fe18092ef, sha256 0f0a3a68d0bdeead4ce8ba5a01c08d8f2f8294fb047ca45256605236d9e1fdf8)
BibTeX
@misc{dc109fe18092ef,
title = {Enhancing anti-tumour immunity through modulating dendritic cell activation by combination therapy with a novel TLR2 agonist and PD-L1 Blockade — Europe PMC PMID:41291775},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41291775},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_109fe18092ef; sha256 0f0a3a68d0bdeead4ce8ba5a01c08d8f2f8294fb047ca45256605236d9e1fdf8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41291775. Agents can read the archived copy with the MCP tool read_document.